We have found that serine hydromethyltransferase 2 (SHMT2) in the serine and glycine sythesis pathway is up-regulated in ccRCC (our unpublished data), indicating increased demand for serine or glycine in ccRCC. This evidence concerns the gene SHMT2 and nonpapillary renal cell carcinoma.